Last reviewed · How we verify
Bleomycin Injection
At a glance
| Generic name | Bleomycin Injection |
|---|---|
| Also known as | Bleomycin Sulfate |
| Sponsor | Jinnah Postgraduate Medical Centre |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Systematic Approach for Children With Orbital Malformation With Sirolimus Use (PHASE3)
- Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation (NA)
- Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations (PHASE2)
- The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial. (NA)
- US-guided Intralesional Injection of Cystic Hygroma - A Case Report (NA)
- Bleomycin Intralesional Injections of Cystic Hygromas (NA)
- A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts (PHASE4)
- Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |